Patient-reported outcome measures should not be the primary outcome in glaucoma clinical trials of disease modification | British Journal of Ophthalmology

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via AAO

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article metrics

Commentary

Patient-reported outcome measures should not be the primary outcome in glaucoma clinical trials of disease modification

Online download statistics by month:

Online download statistics by month: July 2022 to March 2024

	Abstract	Full	Pdf
Jul 2022	4260	89	26
Aug 2022	4093	66	11
Sep 2022	3030	60	8
Oct 2022	363	12	6
Nov 2022	402	6	4
Dec 2022	1035	24	13
Jan 2023	613	24	20
Feb 2023	150	6	4
Mar 2023	120	6	5
Apr 2023	48	4	3
May 2023	172	6	4
Jun 2023	77	4	7
Jul 2023	63	1	1
Aug 2023	130	2	1
Sep 2023	60	4	3
Oct 2023	27	9	4
Nov 2023	80	11	5
Dec 2023	77	7	5
Jan 2024	101	10	9
Feb 2024	51	0	0
Mar 2024	45	2	4
Total	14997	353	143